Ftse Mib
33.901,70
0,81%
DAX
18.130,74
0,76%
S&P 500
5.156,40
0,56%
NASDAQ
16.251,77
0,59%
Bitcoin
63.941,64
-0,09%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kiora Pharmaceuticals Inc (KPRX) Kiora Pharmaceuticals Inc (KPRX) Notizie

Kiora Pharmaceuticals Inc

KPRX
0,475
-0,0383 (-7,46%)
Ultimo aggiornamento: 15:49:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/2/202422:40EDGAR2Form S-3 - Registration statement under Securities Act of..
14/2/202422:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202421:51EDGAR2Form D - Notice of Exempt Offering of Securities
14/2/202402:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:23EDGAR2Form 8-K - Current report
09/2/202422:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202416:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202413:01EDGAR2Form 8-K - Current report
31/1/202423:14EDGAR2Form 8-K - Current report
16/1/202423:16EDGAR2Form 8-K - Current report
09/11/202313:02EDGAR2Form 8-K - Current report
09/11/202313:01EDGAR2Form 8-K - Current report
09/11/202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202312:05EDGAR2Form 8-K - Current report
13/10/202323:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/10/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202313:00EDGAR2Form 8-K - Current report
01/9/202313:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/9/202313:00EDGAR2Form 8-K - Current report
10/8/202323:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/8/202313:14EDGAR2Form 8-K - Current report
08/8/202313:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202313:00EDGAR2Form 8-K - Current report
21/7/202322:49EDGAR2Form DEF 14A - Other definitive proxy statements
20/7/202323:01EDGAR2Form 8-K - Current report
11/7/202323:00EDGAR2Form PRE 14A - Other preliminary proxy statements
23/6/202314:35GLOBELife Science Investor Forum: Presentations Now Available for..
20/6/202316:58GLOBELife Science Investor Forum Agenda Announced for June 22nd
Apertura: 0,499 Min: 0,471 Max: 0,5055
Chiusura: 0,5133

La tua Cronologia

NASDAQ
KPRX
Kiora Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network